[en] Background: Bordetella bronchiseptica (Bb) infection commonly causes respiratory disease in dogs. Gentamicin delivered by aerosol maximizes local drug delivery without
systemic absorption but clinical response to protocols remains undetermined.
Objectives: To compare the clinical response to 2 protocols of aerosolized delivery
of gentamicin in bordetellosis.
Bemis, D.A., Greisen, H.A., Appel, M.J., Pathogenesis of canine bordetellosis (1977) J Infect Dis, 135, pp. 753-762
Bemis, D.A., Bordetella and Mycoplasma respiratory infections in dogs and cats (1992) Vet Clin North Am Small Anim Pract, 22, pp. 1173-1186
Keil, D.J., Fenwick, B., Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs (1998) J Am Vet Med Assoc, 212, pp. 200-207
Priestnall, S.L., Mitchell, J.A., Walker, C.A., New and emerging pathogens in canine infectious respiratory disease (1992) Vet Pathol, 51, pp. 492-504
Schulz, B.S., Kurz, S., Weber, K., Detection of respiratory viruses and Bordetella bronchiseptica in dogs with acute respiratory tract infections (2014) Vet J, 201, pp. 365-369
Lavan, R., Knesl, O., Prevalence of canine infectious respiratory pathogens in asymptomatic dogs presented at US animal shelters (2015) J Small Anim Pract, 56, pp. 572-576
Decaro, N., Mari, V., Larocca, V., Molecular surveillance of traditional and emerging pathogens associated with canine infectious respiratory disease (2016) Vet Microbiol, 192, pp. 21-25
Canonne, A.M., Billen, F., Tual, C., Quantitative PCR and cytology of bronchoalveolar lavage fluid in dogs with Bordetella bronchiseptica infection (2016) J Vet Intern Med, 30, pp. 1204-1209
Wöhrer, D., Sperger, J., Bagrinovschi, K., Age-related presence of selected viral and bacterial pathogens in paraffin-embedded lung samples of dogs with pneumonia (2016) Acta Vet Hung, 64 (1), pp. 103-115
Taha-Abdelaziz, K., Bassel, L.L., Harness, M.L., Clark, M.E., Register, K.B., Caswell, J.L., Cilia-associated bacteria in fatal Bordetella bronchiseptica pneumonia of dogs and cats (2016) J Vet Diagn Invest, 28, pp. 369-376
Radhakrishnan, A., Drobatz, K.J., Culp, W.T., Community-acquired infectious pneumonia in puppies: 65 cases (1993-2002) (2007) J Am Vet Med Assoc, 230, pp. 1493-1497
Dworkin, M.S., Sullivan, P.S., Buski, S.E., Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients (1999) Clin Infect Dis, 28, pp. 1095-1099
Ner, Z., Ross, L.A., Horn, M.V., Bordetella bronchiseptica infection in pediatric lung transplant recipients (2003) Pediatr Transplant, 7, pp. 413-417
Yacoub, A.T., Katayama, M., Tran, J., Zadikany, R., Kandula, M., Greene, J.N., Bordetella bronchiseptica in the immunosuppressed population - a case series and review (2014) Mediterr J Hematol Infect Dis, 6
Rycroft, A., Tsounakou, E., Chalker, V., Serological evidence of Mycoplasma cynos infection in canine infectious respiratory disease (2007) Vet Microbiol, 120, pp. 358-362
Zeugswetter, F., Weissenböck, H., Shibly, S., Lethal bronchopneumonia caused by Mycoplasma cynos in a litter of golden retriever puppies (2007) Vet Rec, 161, pp. 626-627
Mannering, S., Mcauliffe, L., Lawes, J., Strain typing of Mycoplasma cynos isolates from dogs with respiratory disease (2009) Vet Microbiol, 135, pp. 292-296
Sowman, H.R., Cave, N.J., Dunowska, M., A survey of canine respiratory pathogens in New Zealand dogs (2018) N Z Vet J, 66, pp. 236-242
Anderton, T.L., Maskell, D.J., Preston, A., Ciliostasis is a key early event during colonization of canine tracheal tissue by Bordetella bronchiseptica (2004) Microbiology, 150, pp. 2843-2855
Buboltz, A.M., Nicholson, T.L., Weyrich, L.S., Harvill, E.T., Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica (2009) Infect Immun, 77, pp. 3969-3977
Cattelan, N., Dubey, P., Arnal, L., Yantorno, O.M., Deora, R., Bordetella biofilms: a lifestyle leading to persistent infections (2016) Pathog Dis Feb, 74
Pilione, M.R., Harvill, E.T., The Bordetella Bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance (2006) Infect Immun, 74, pp. 1043-1049
Skinner, J.A., Pilione, M.R., Shen, H., Harvill, E.T., Yuk, M.H., Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence (2005) J Immunol, 175, pp. 4647-4652
Siciliano, N.A., Skinner, J.A., Yuk, M.H., Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response (2006) J Immunol, 177, pp. 7131-7138
Steinfeld, A., Prenger-Berninghoff, E., Bauer, N., Weiß, R., Moritz, A., Bacterial susceptibility testings of the lower airways of diseased dogs (2012) Tierarztl Prax Ausg K Kleintiere Heimtiere, 40, pp. 309-317
Murray, M.P., Govan, J.R., Doherty, C.J., A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis (2011) Am J Respir Crit Care Med, 183, pp. 491-499
Yang, J.W., Fan, L.C., Lu, H.W., Miao, X.Y., Mao, B., Xu, J.F., Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis (2016) Clin Respir J, 10, pp. 731-739
Soltaninejad, F., Kheiri, S., Habibian, R., Evaluation effects of nebulized gentamicin in exacerbation of chronic obstructive lung disease (2016) J Res Med Sci, 21, p. 56
Heyder, J., Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery (2004) Proc Am Thorac Soc, 1 (4), pp. 315-320
Lipworth, B., Manoharan, A., Anderson, W., Unlocking the quiet zone: the small airway asthma phenotype (2014) Lancet Respir Med, 2, pp. 497-506
Bemis, D.A., Appel, M.J., Aerosol Nolvasan treatment of Bordetella bronchiseptica in dogs (1977) Vet Med Small Anim Clin, 72, pp. 53-55
Dehard, S., Bernaerts, F., Peeters, D., Comparison of bronchoalveolar lavage cytospins and smears in dogs and cats (2008) J Am Anim Hosp Assoc, 44, pp. 285-294
Peeters, D., McKiernan, B.C., Weisiger, R.M., Quantitative bacterial cultures and cytological examination of bronchoalveolar lavage specimens in dogs (2000) J Vet Intern Med, 14, pp. 534-541
Riviere, J.E., Silver, G.R., Coppoc, G.L., Richardson, R.C., Gentamicin aerosol therapy in 18 dogs: failure to induce detectable serum concentrations of the drug (1981) J Am Vet Med Assoc, 179, pp. 166-168
Conway, H., Dix, K.J., McDonald, J.D., Comparison of inhalation toxicity studies of gentamicin in rats and dogs (2013) Inhal Toxicol, 25, pp. 714-724
Boisson, M., Mimoz, O., Hadzic, M., Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients (2018) J Antimicrob Chemother, 73, pp. 2830-2837
Hassan, N.A., Awdallah, F.F., Abbassi, M.M., Sabry, N.A., Nebulized versus IV Amikacin as adjunctive antibiotic for hospital and ventilator-acquired pneumonia Postcardiac surgeries: a randomized controlled trial (2018) Crit Care Med, 46, pp. 45-52
Joffe, D.J., Lelewski, R., Weese, J., Factors associated with development of canine infectious respiratory disease complex (CIRDC) in dogs in 5 Canadian small animal clinics (2016) Can Vet J, 57, pp. 46-51
McKenzie, H.C., Murray, M.J., Concentrations of gentamicin in serum and bronchial lavage fluid after intravenous and aerosol administration of gentamicin to horses (2000) Am J Vet Res, 61, pp. 1185-1190
Burton, A.J., Giguère, S., Arnold, R.D., Pharmacokinetics, pulmonary disposition and tolerability of liposomal gentamicin and free gentamicin in foals (2015) Equine Vet J, 47, pp. 467-472
